United States · Platforms & data · TradingView
J&J looks to buy Ollin Biosciences for up to $3.4 billion, FT says

Detailed summary
Johnson & Johnson NYSE:JNJ could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with the matter.Here are some details:
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingview.com)




